Evelo Biosciences Inc. (EVLO) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-08
10:21 am
Purchase		2021-02-0513GEvelo Biosciences, Inc.
EVLO		FMR LLC340,168
14.729%		178,047increase
(+109.82%)		Filing
History
2021-02-04
5:30 pm
Purchase		2021-02-0213DEvelo Biosciences, Inc.
EVLO		Flagship Ventures Fund V, L.P.1,151,503
43.900%		5,716increase
(+0.50%)		Filing
History
Goto Prev, 0, 1